Internal Medicine, Hepatology · Tampa, FL
NPI
1477520617
Since 2006
Specialty
Internal Medicine, Hepatology
Code 207RI0008X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
409 Bayshore Blvd
Tampa, FL, 33606
Phone (813) 844-5460
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
493 services
Medicare patients, 2024
215
Average age 68
Drug cost, 2024
$1.4M
1,575 prescriptions
Company payments, 2025
$449
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Basem Alkurdi was code 99233 (hospital e&m - subsequent), 258 times for 76 patients. In total Basem Alkurdi billed 493 services in 17 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 258 | 76 | $89.38 | $23K |
| 99214 Office E&M - Established | Office | 123 | 99 | $71.16 | $8,753 |
| 99223 Hospital E&M - Initial | Facility | 46 | 41 | $132.68 | $6,103 |
| 99205 Office E&M - New | Office | 29 | 29 | $137.11 | $3,976 |
By year: 2022 $51K for 600 services; 2023 $61K for 643 services; 2024 $44K for 493 services.
Medicare prescription drug claims, 2024
In 2024, the drug Basem Alkurdi prescribed most often to Medicare patients was Tacrolimus, with 282 prescriptions and refills. In total Basem Alkurdi wrote 1,575 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 282 | 603 | 121 | $40K |
| Xifaxan Rifaximin | 213 | 213 | 34 | $658K |
| Ursodiol Generic | 166 | 326 | 68 | $24K |
| Mycophenolate Mofetil Generic | 116 | 262 | 56 | $7,559 |
| Envarsus Xr Tacrolimus | 93 | 168 | 27 | $93K |
| Lactulose Generic | 68 | 84 | 21 | $4,038 |
| Furosemide Generic | 63 | 116 | 24 | $191 |
| Spironolactone Generic | 60 | 123 | 22 | $462 |
| Prednisone Generic | 59 | 104 | 26 | $312 |
| Entecavir Generic | 54 | 91 | 14 | $7,631 |
| Mycophenolic Acid Mycophenolate Sodium | 38 | 102 | 21 | $7,583 |
| Vemlidy Tenofovir Alafenamide | 34 | 34 | Under 11 | $46K |
| Rezdiffra Resmetirom | 24 | 24 | Under 11 | $96K |
| Everolimus Generic | 22 | 22 | Under 11 | $43K |
| Lokelma Sodium Zirconium Cyclosilicate | 20 | 20 | Under 11 | $14K |
Brand drugs: 475 claims; generic drugs: 1,100 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Basem Alkurdi $449 ($449 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $245.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.